Correlation Between Pasithea Therapeutics and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Crispr Therapeutics AG, you can compare the effects of market volatilities on Pasithea Therapeutics and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Crispr Therapeutics.
Diversification Opportunities for Pasithea Therapeutics and Crispr Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pasithea and Crispr is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Crispr Therapeutics
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Crispr Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 1.01 times less risky than Crispr Therapeutics. The stock trades about -0.31 of its potential returns per unit of risk. The Crispr Therapeutics AG is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 4,804 in Crispr Therapeutics AG on August 23, 2024 and sell it today you would lose (175.00) from holding Crispr Therapeutics AG or give up 3.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Pasithea Therapeutics |
| Crispr Therapeutics |
Pasithea Therapeutics and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Crispr Therapeutics
The main advantage of trading using opposite Pasithea Therapeutics and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Pasithea Therapeutics vs. ZyVersa Therapeutics | Pasithea Therapeutics vs. Sonnet Biotherapeutics Holdings | Pasithea Therapeutics vs. Zura Bio Limited | Pasithea Therapeutics vs. Phio Pharmaceuticals Corp |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |